Oxetane and azetidine scaffolds are important motifs in medicinal chemistry, yet their direct interconversion remains challenging. Now it has been shown that oxetanes can be converted into azetidines via a broadly applicable, non-redox skeletal editing strategy, enabling rapid access to structurally diverse azetidine analogues for drug discovery.